fbpx

Three suitors for Bausch + Lomb

 

According to specialized news website Bloomberg, Abbott Laboratories, Johnson & Johnson and Sanofi are in the running to acquire Bausch + Lomb, which Warburg Pincus LLC is seeking to sell. Merck & Co and Pfizer have also shown interest in the company, according to Bloomberg, which has quoted anonymous sources.

 

Warburg expects to receive the first-round bids by the end of January, and is said to be seeking at least $10 billion. Such a transaction would be the third biggest sale ever by a private-equity-controlled company. The company had paid about $4.6 billion in 2007 for Bausch + Lomb, an acquisition that included debt. Since then, its earnings before interest, taxes, depreciation and amortization have risen from $400 million to just under $700 million. Its 2013 projected earnings are about $800 million.

 

Bausch + Lomb’s businesses are pharmaceuticals, vision care and surgical. About 40% of its sales come from North America, 33% from Europe and the rest from Asia and Latin America. Its Canadian head office is located in Vaughan, Ontario.

Source:

http://www.bloomberg.com/news/2013-01-03/abbott-j-j-sanofi-said-to-show-interest-in-bausch-lomb-bid.html

 

 

Featured Posts

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read more

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read more

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read more

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read More

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read More

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read More

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read More

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read more

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read more

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read more

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read more

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read more

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read more